We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
EPA Draft CCL 6 Prioritizes Microplastics: Technical and Policy Implications for Reliable Detection in Drinking Water
Summary
This research examined pulmonary toxicity of inhaled microplastics, assessing inflammatory responses, oxidative stress, and cellular damage in lung tissue. The findings demonstrate dose-dependent toxicological effects of plastic particles in the respiratory system, relevant to human health risk assessment for airborne microplastic exposure.
Abstract On April 2, 2026, the U.S. Environmental Protection Agency (EPA) and Department of Health and Human Services announced the prioritization of microplastics, pharmaceuticals, PFAS, and disinfection byproducts as candidate groups on the draft Sixth Contaminant Candidate List (CCL 6). This marks the first time microplastics have been designated at the group level for drinking water consideration. While this represents a significant policy milestone, reliable detection of microplastics at environmentally relevant concentrations remains technically challenging due to stochastic sampling effects. This brief examines the implications of CCL 6 and outlines practical monitoring strategies grounded in Poisson statistics, large-volume sampling, and image-based analysis. Scalable, field-deployable approaches—including smartphone-enabled data collection—are proposed to support high-density, nationwide monitoring.